netFormulary NHS
Coventry and Warwickshire Area Prescribing Committee

Looking for Adalimumab found 11 matches

Open monograph to display formulary status BNF Category
(RA & PA)
Musculoskeletal system - Drugs affecting the immune response - 10.01.03
(Ankylosing spondylitis /plaque psoriasis)
Skin - Drugs affecting the immune response - 13.05.03
  Adalimumab injection
Gastro-intestinal system - Cytokine inhibitors - 01.05.03

Linkslink in drug section Link to Drug Section link in subsection Link to document
link in drug section NICE TA146: Psoriasis - adalimumab (13.05.03)
link in subsection NICE TA187: Infliximab and adalimumab for the treatment of Crohn’s disease (01.05.03)
link in subsection NICE TA195: Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a TNF inhibitor (10.01.03)
link in subsection NICE TA199: Psoriatic arthritis - etanercept, infliximab and adalimumab (NICE TA199) (10.01.03)
link in subsection NICE TA329: Infliximab, adalimumab and golimumab for treating moderately to severely active ulcerative colitis after the failure of conventional therapy (01.05.03)
link in subsection NICE TA373: Abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis (10.01.03)
link in subsection NICE TA455 -Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people (13.05.03)
link in drug section NICE TA460: Adalimumab and dexamethasone for treating non-infectious uveitis (11.04.01)